123 related articles for article (PubMed ID: 33824024)
1. High-dose pyridoxine treatment for inherited glycosylphosphatidylinositol deficiency.
Tanigawa J; Nabatame S; Tominaga K; Nishimura Y; Maegaki Y; Kinosita T; Murakami Y; Ozono K
Brain Dev; 2021 Jun; 43(6):680-687. PubMed ID: 33824024
[TBL] [Abstract][Full Text] [Related]
2. Pyridoxine or pyridoxal-5-phosphate treatment for seizures in glycosylphosphatidylinositol deficiency: A cohort study.
Bayat A; Aledo-Serrano A; Gil-Nagel A; Korff CM; Thomas A; Boßelmann C; Weber Y; Gardella E; Lund AM; de Sain-van der Velden MGM; Møller RS
Dev Med Child Neurol; 2022 Jun; 64(6):789-798. PubMed ID: 35080266
[TBL] [Abstract][Full Text] [Related]
3. Early infancy-onset stimulation-induced myoclonic seizures in three siblings with inherited glycosylphosphatidylinositol (GPI) anchor deficiency.
Mogami Y; Suzuki Y; Murakami Y; Ikeda T; Kimura S; Yanagihara K; Okamoto N; Kinoshita T
Epileptic Disord; 2018 Feb; 20(1):42-50. PubMed ID: 29444765
[TBL] [Abstract][Full Text] [Related]
4. Mutations in PIGU Impair the Function of the GPI Transamidase Complex, Causing Severe Intellectual Disability, Epilepsy, and Brain Anomalies.
Knaus A; Kortüm F; Kleefstra T; Stray-Pedersen A; Đukić D; Murakami Y; Gerstner T; van Bokhoven H; Iqbal Z; Horn D; Kinoshita T; Hempel M; Krawitz PM
Am J Hum Genet; 2019 Aug; 105(2):395-402. PubMed ID: 31353022
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry.
Basura GJ; Hagland SP; Wiltse AM; Gospe SM
Eur J Pediatr; 2009 Jun; 168(6):697-704. PubMed ID: 18762976
[TBL] [Abstract][Full Text] [Related]
6. A novel PIGN mutation and prenatal diagnosis of inherited glycosylphosphatidylinositol deficiency.
Nakagawa T; Taniguchi-Ikeda M; Murakami Y; Nakamura S; Motooka D; Emoto T; Satake W; Nishiyama M; Toyoshima D; Morisada N; Takada S; Tairaku S; Okamoto N; Morioka I; Kurahashi H; Toda T; Kinoshita T; Iijima K
Am J Med Genet A; 2016 Jan; 170A(1):183-8. PubMed ID: 26419326
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of Levetiracetam-Induced Behavioral Side Effects by Pyridoxine. A Randomized Double Blind Controlled Study.
Mahmoud A; Tabassum S; Al Enazi S; Lubbad N; Al Wadei A; Al Otaibi A; Jad L; Benini R
Pediatr Neurol; 2021 Jun; 119():15-21. PubMed ID: 33823377
[TBL] [Abstract][Full Text] [Related]
8. [Inherited GPI deficiency; a new disease with intellectual disability and epilepsy].
Murakami Y; Kinoshita T
Nihon Rinsho; 2015 Jul; 73(7):1227-37. PubMed ID: 26165085
[TBL] [Abstract][Full Text] [Related]
9. Establishment of mouse model of inherited PIGO deficiency and therapeutic potential of AAV-based gene therapy.
Kuwayama R; Suzuki K; Nakamura J; Aizawa E; Yoshioka Y; Ikawa M; Nabatame S; Inoue KI; Shimmyo Y; Ozono K; Kinoshita T; Murakami Y
Nat Commun; 2022 Jun; 13(1):3107. PubMed ID: 35661110
[TBL] [Abstract][Full Text] [Related]
10. Randomized, controlled trial of high-dose intravenous pyridoxine in the treatment of recurrent seizures in children.
Jiao FY; Gao DY; Takuma Y; Wu S; Liu ZY; Zhang XK; Lieu NS; Ge ZL; Chui W; Li HR; Cao YM; Bai AN; Liu SB
Pediatr Neurol; 1997 Jul; 17(1):54-7. PubMed ID: 9308977
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of pyridoxine in early-onset idiopathic intractable seizures in children.
Mishra D; Kalra V; Seth R; Gulati S; Saha N
Indian J Pediatr; 2010 Nov; 77(11):1252-6. PubMed ID: 20830535
[TBL] [Abstract][Full Text] [Related]
12. Pyridoxine-dependent epilepsies: an observational study on clinical, diagnostic, therapeutic and prognostic features in a pediatric cohort.
Falsaperla R; Vari MS; Toldo I; Murgia A; Sartori S; Vecchi M; Suppiej A; Burlina A; Mastrangelo M; Leuzzi V; Marchiani V; De Liso P; Capovilla G; Striano P; Vitaliti G;
Metab Brain Dis; 2018 Feb; 33(1):261-269. PubMed ID: 29178011
[TBL] [Abstract][Full Text] [Related]
13. Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy.
Wang HS; Kuo MF; Chou ML; Hung PC; Lin KL; Hsieh MY; Chang MY
Arch Dis Child; 2005 May; 90(5):512-5. PubMed ID: 15851435
[TBL] [Abstract][Full Text] [Related]
14. Glycosylphosphatidylinositol (GPI) anchor deficiency caused by mutations in PIGW is associated with West syndrome and hyperphosphatasia with mental retardation syndrome.
Chiyonobu T; Inoue N; Morimoto M; Kinoshita T; Murakami Y
J Med Genet; 2014 Mar; 51(3):203-7. PubMed ID: 24367057
[TBL] [Abstract][Full Text] [Related]
15. Confirmation of mutations in
Plecko B; Zweier M; Begemann A; Mathis D; Schmitt B; Striano P; Baethmann M; Vari MS; Beccaria F; Zara F; Crowther LM; Joset P; Sticht H; Papuc SM; Rauch A
J Med Genet; 2017 Dec; 54(12):809-814. PubMed ID: 28391250
[TBL] [Abstract][Full Text] [Related]
16. Epileptic apnea in a patient with inherited glycosylphosphatidylinositol anchor deficiency and PIGT mutations.
Kohashi K; Ishiyama A; Yuasa S; Tanaka T; Miya K; Adachi Y; Sato N; Saitsu H; Ohba C; Matsumoto N; Murakami Y; Kinoshita T; Sugai K; Sasaki M
Brain Dev; 2018 Jan; 40(1):53-57. PubMed ID: 28728837
[TBL] [Abstract][Full Text] [Related]
17. High-Fidelity Simulation Scenario: Pyridoxine-Dependent Epilepsy and Treatment.
Anderson J; Arboleda N; Calleo V
MedEdPORTAL; 2018 Sep; 14():10753. PubMed ID: 30800953
[TBL] [Abstract][Full Text] [Related]
18. Phenotype-genotype correlations of PIGO deficiency with variable phenotypes from infantile lethality to mild learning difficulties.
Tanigawa J; Mimatsu H; Mizuno S; Okamoto N; Fukushi D; Tominaga K; Kidokoro H; Muramatsu Y; Nishi E; Nakamura S; Motooka D; Nomura N; Hayasaka K; Niihori T; Aoki Y; Nabatame S; Hayakawa M; Natsume J; Ozono K; Kinoshita T; Wakamatsu N; Murakami Y
Hum Mutat; 2017 Jul; 38(7):805-815. PubMed ID: 28337824
[TBL] [Abstract][Full Text] [Related]
19. Effects of Vitamin B6 (Pyridoxine) and a B Complex Preparation on Dreaming and Sleep.
Adventure-Heart DJ; Madden NA; Delfabbro P
Percept Mot Skills; 2018 Jun; 125(3):451-462. PubMed ID: 29665762
[TBL] [Abstract][Full Text] [Related]
20. Phenotype, biochemical features, genotype and treatment outcome of pyridoxine-dependent epilepsy.
Al Teneiji A; Bruun TU; Cordeiro D; Patel J; Inbar-Feigenberg M; Weiss S; Struys E; Mercimek-Mahmutoglu S
Metab Brain Dis; 2017 Apr; 32(2):443-451. PubMed ID: 27882480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
